What We're Reading: Page 275
Industry reads hand-picked by our editors
Jan 31, 2018
-
Kaiser Health News
Expert advice for the corporate titans taking on health care
-
Fortune
Female founders got 2% of venture capital dollars in 2017
-
The Wall Street Journal
Investor who rode pivot from biotech to Bitcoin sells big stake
-
The New York Times
Preventive care saves money? Sorry, it’s too good to be true
Jan 30, 2018
Jan 29, 2018
-
Reuters
How Sanofi's setback could lead to better dengue vaccines
-
Bloomberg
Hong Kong seeks to cash in on frenzy for Chinese drug stocks
-
Chemical & Engineering News
Uncovering the hidden signs of organ transplant rejection
Jan 26, 2018
-
NPR
An uncle's overdose spurs Medicaid official to change course
-
CBS
Patients seeking "death with dignity" face drug price-gouging
-
Genetic Engineering & Biotechnology News
Dopamine receptor–drug structure could aid development of safer antipsychotics
-
Time
This tiny implant can deliver medicine to your brain with the push of a button
Jan 25, 2018
-
Kaiser Health News
Big pharma greets hundreds of ex-federal workers at the ‘revolving door’
-
Bloomberg
Puma plunges as cancer drug setback stuns Wall Street
-
Salon
With macaque monkey cloning, China emerges as a new leader in cloning biotech
-
Scientific American
The pharma exec behind the first approved gene therapy is hunting for his next big break
Jan 24, 2018
-
Kaiser Health News
University under fire for off-the-grid herpes vaccine experiments
-
Science
NIH’s new clinical trial policy kicks in despite concerns from basic behavioral researchers
-
Bloomberg
China pharma tycoon mulls $500 million IPO of clinic arm
-
The Tennessean
Big pharma likes to treat opioid addiction with medication. Is that a problem?
Jan 23, 2018
-
Financial Times
Big pharma makes strongest start to M&A for a decade
-
Xconomy
Tmunity reels in $100M for “next generation” cancer immunotherapy
-
The Wall Street Journal
China, unhampered by rules, races ahead in gene-editing trials
Previous
